skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Adult remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab

Yanai, Henit ; Lichtenstein, Lev ; Assa, Amit ; Mazor, Yoav ; Weiss, Batia ; Levine, Arie ; Ron, Yulia ; Kopylov, Uri ; Bujanover, Yoram ; Rosenbach, Yoram ; Ungar, Bella ; Eliakim, Rami ; Chowers, Yehuda ; Shamir, Raanan ; Fraser, Gerald ; Dotan, Iris ; Ben-Horin, Shomron

Clinical gastroenterology and hepatology, 2015-03, Vol.13 (3), p.522-530.e2 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

Dörner, Thomas ; Posch, Maximilian Georg ; Li, Yue ; Petricoul, Olivier ; Cabanski, Maciej ; Milojevic, Julie Marie ; Kamphausen, Esther ; Valentin, Marie-Anne ; Simonett, Claudia ; Mooney, Louise ; Hüser, Andreas ; Gram, Hermann ; Wagner, Frank Dietrich ; Oliver, Stephen John

Annals of the rheumatic diseases, 2019-05, Vol.78 (5), p.641-647 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
3
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study

Cohen, Yehuda Z ; Butler, Allison L ; Millard, Katrina ; Witmer-Pack, Maggi ; Levin, Rebeka ; Unson-O'Brien, Cecilia ; Patel, Roshni ; Shimeliovich, Irina ; Lorenzi, Julio C C ; Horowitz, Jill ; Walsh, Stephen R ; Lin, Shu ; Weiner, Joshua A ; Tse, Anna ; Sato, Alicia ; Bennett, Chelsey ; Mayer, Bryan ; Seaton, Kelly E ; Yates, Nicole L ; Baden, Lindsey R ; deCamp, Allan C ; Ackerman, Margaret E ; Seaman, Michael S ; Tomaras, Georgia D ; Nussenzweig, Michel C ; Caskey, Marina Landay, Alan

PloS one, 2019-08, Vol.14 (8), p.e0219142 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
4
Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients
Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients

Heppt, M.V. ; Schlaak, M. ; Eigentler, T.K. ; Kähler, K.C. ; Kiecker, F. ; Loquai, C. ; Meier, F. ; Tomsitz, D. ; Brenner, N. ; Niesert, A.C. ; Thonke, R. ; Hauschild, A. ; Berking, C.

Annals of oncology, 2017-12, Vol.28 (12), p.3104-3106 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Galcanezumab: First Global Approval
Galcanezumab: First Global Approval
Material Type:
Artigo 		Adicionar ao Meu Espaço

Galcanezumab: First Global Approval

Lamb, Yvette N.

Drugs (New York, N.Y.), 2018-11, Vol.78 (16), p.1769-1775 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
6
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation

MacGlashan, Donald W., MD, PhD ; Saini, Sarbjit S., MD

Journal of allergy and clinical immunology, 2013-10, Vol.132 (4), p.906-911.e4 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
7
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development
Material Type:
Artigo 		Adicionar ao Meu Espaço

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development

Todeschini, Marta ; Cortinovis, Monica ; Perico, Norberto ; Poli, Francesca ; Innocente, Annalisa ; Cavinato, Regiane Aparecida ; Gotti, Eliana ; Ruggenenti, Piero ; Gaspari, Flavio ; Noris, Marina ; Remuzzi, Giuseppe ; Casiraghi, Federica

The Journal of immunology (1950), 2013-09, Vol.191 (5), p.2818-2828 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma

Carlsson, Mats ; Braddock, Martin ; Li, Yuling ; Wang, Jihong ; Xu, Weichen ; White, Nicholas ; Megally, Ayman ; Hunter, Gillian ; Colice, Gene

Drug safety, 2019-06, Vol.42 (6), p.769-784 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
9
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Langley, Richard G ; Elewski, Boni E ; Lebwohl, Mark ; Reich, Kristian ; Griffiths, Christopher E.M ; Papp, Kim ; Puig, Lluís ; Nakagawa, Hidemi ; Spelman, Lynda ; Sigurgeirsson, Bárður ; Rivas, Enrique ; Tsai, Tsen-Fang ; Wasel, Norman ; Tyring, Stephen ; Salko, Thomas ; Hampele, Isabelle ; Notter, Marianne ; Karpov, Alexander ; Helou, Silvia ; Papavassilis, Charis

The New England journal of medicine, 2014-07, Vol.371 (4), p.326-338 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies
A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies

Garcês, Sandra ; Antunes, Marília ; Benito-Garcia, Elizabeth ; da Silva, José Canas ; Aarden, Lucien ; Demengeot, Jocelyne

Annals of the rheumatic diseases, 2014-06, Vol.73 (6), p.1138-1143 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (15.282)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (16.172)
  2. magazinearticle  (3)
  3. Web Resources  (1)
  4. Book Chapters  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1987  (1.155)
  2. 1987Até1995  (2.399)
  3. 1996Até2004  (3.298)
  4. 2005Até2014  (6.382)
  5. Após 2014  (2.944)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (16.020)
  2. Japonês  (2.405)
  3. Espanhol  (35)
  4. Francês  (31)
  5. Alemão  (30)
  6. Português  (25)
  7. Russo  (13)
  8. Chinês  (11)
  9. Holandês  (8)
  10. Italiano  (6)
  11. Sueco  (4)
  12. Dinamarquês  (4)
  13. Norueguês  (3)
  14. Polonês  (3)
  15. Hebraico  (3)
  16. Serbian  (1)
  17. Tcheco  (1)
  18. Coreano  (1)
  19. Turco  (1)
  20. Croatian  (1)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.